Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
855 | 3004 | 28.7 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
136 | 3 | CYCLODEXTRIN//INCLUSION COMPLEX//CALIXARENES | 65522 |
366 | 2 | CYCLODEXTRIN//INCLUSION COMPLEX//BETA CYCLODEXTRIN | 17315 |
855 | 1 | INCLUSION COMPLEX//CYCLODEXTRIN//HYDROXYPROPYL BETA CYCLODEXTRIN | 3004 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INCLUSION COMPLEX | authKW | 1867645 | 22% | 28% | 659 |
2 | CYCLODEXTRIN | authKW | 1107204 | 28% | 13% | 842 |
3 | HYDROXYPROPYL BETA CYCLODEXTRIN | authKW | 959405 | 7% | 44% | 214 |
4 | BETA CYCLODEXTRIN | authKW | 746808 | 16% | 15% | 479 |
5 | 2 HYDROXYPROPYL BETA CYCLODEXTRIN | authKW | 464883 | 3% | 50% | 91 |
6 | PHASE SOLUBILITY | authKW | 394112 | 2% | 71% | 55 |
7 | JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY | journal | 379179 | 10% | 12% | 308 |
8 | PHASE SOLUBILITY STUDIES | authKW | 182923 | 1% | 75% | 24 |
9 | PHASE SOLUBILITY DIAGRAMS | authKW | 175666 | 1% | 79% | 22 |
10 | HP BETA CD | authKW | 166686 | 1% | 46% | 36 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 26959 | 55% | 0% | 1650 |
2 | Chemistry, Medicinal | 12359 | 19% | 0% | 583 |
3 | Chemistry, Multidisciplinary | 8227 | 35% | 0% | 1046 |
4 | Chemistry, Applied | 1041 | 6% | 0% | 188 |
5 | Chemistry, Analytical | 510 | 7% | 0% | 212 |
6 | Chemistry, Organic | 296 | 6% | 0% | 185 |
7 | Polymer Science | 126 | 4% | 0% | 111 |
8 | Food Science & Technology | 118 | 3% | 0% | 104 |
9 | Thermodynamics | 91 | 2% | 0% | 61 |
10 | Chemistry, Physical | 88 | 7% | 0% | 213 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIT FUNCT BIOMAT | 41274 | 1% | 25% | 16 |
2 | COMPOUND ID PURIFICAT | 40652 | 0% | 100% | 4 |
3 | PL CHEM ORGAN NAT CPDS ENGN | 33192 | 0% | 47% | 7 |
4 | AREA TECN FARMACEUT | 31756 | 0% | 63% | 5 |
5 | PHARMACEUT TECHNOL | 29937 | 5% | 2% | 162 |
6 | LEMB | 28374 | 0% | 31% | 9 |
7 | CHU TOUR 4 | 28226 | 0% | 56% | 5 |
8 | NSM | 27526 | 0% | 18% | 15 |
9 | AGR PROD STORAGE PROC | 22865 | 0% | 75% | 3 |
10 | BIOACT MOL GRP | 21669 | 0% | 27% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY | 379179 | 10% | 12% | 308 |
2 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 62351 | 10% | 2% | 312 |
3 | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 36296 | 5% | 3% | 139 |
4 | JOURNAL OF PHARMACEUTICAL SCIENCES | 25136 | 6% | 2% | 167 |
5 | JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY | 20327 | 1% | 5% | 40 |
6 | AAPS PHARMSCITECH | 13232 | 2% | 3% | 49 |
7 | PHARMAZIE | 13191 | 4% | 1% | 108 |
8 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 12491 | 2% | 2% | 66 |
9 | STP PHARMA SCIENCES | 12074 | 1% | 4% | 28 |
10 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 10448 | 2% | 2% | 62 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INCLUSION COMPLEX | 1867645 | 22% | 28% | 659 | Search INCLUSION+COMPLEX | Search INCLUSION+COMPLEX |
2 | CYCLODEXTRIN | 1107204 | 28% | 13% | 842 | Search CYCLODEXTRIN | Search CYCLODEXTRIN |
3 | HYDROXYPROPYL BETA CYCLODEXTRIN | 959405 | 7% | 44% | 214 | Search HYDROXYPROPYL+BETA+CYCLODEXTRIN | Search HYDROXYPROPYL+BETA+CYCLODEXTRIN |
4 | BETA CYCLODEXTRIN | 746808 | 16% | 15% | 479 | Search BETA+CYCLODEXTRIN | Search BETA+CYCLODEXTRIN |
5 | 2 HYDROXYPROPYL BETA CYCLODEXTRIN | 464883 | 3% | 50% | 91 | Search 2+HYDROXYPROPYL+BETA+CYCLODEXTRIN | Search 2+HYDROXYPROPYL+BETA+CYCLODEXTRIN |
6 | PHASE SOLUBILITY | 394112 | 2% | 71% | 55 | Search PHASE+SOLUBILITY | Search PHASE+SOLUBILITY |
7 | PHASE SOLUBILITY STUDIES | 182923 | 1% | 75% | 24 | Search PHASE+SOLUBILITY+STUDIES | Search PHASE+SOLUBILITY+STUDIES |
8 | PHASE SOLUBILITY DIAGRAMS | 175666 | 1% | 79% | 22 | Search PHASE+SOLUBILITY+DIAGRAMS | Search PHASE+SOLUBILITY+DIAGRAMS |
9 | HP BETA CD | 166686 | 1% | 46% | 36 | Search HP+BETA+CD | Search HP+BETA+CD |
10 | INCLUSION COMPLEXATION | 129298 | 2% | 27% | 48 | Search INCLUSION+COMPLEXATION | Search INCLUSION+COMPLEXATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BREWSTER, ME , LOFTSSON, T , (2007) CYCLODEXTRINS AS PHARMACCUTICAL SOLUBILIZERS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 59. ISSUE 7. P. 645 -666 | 110 | 66% | 734 |
2 | UEKAMA, K , HIRAYAMA, F , IRIE, T , (1998) CYCLODEXTRIN DRUG CARRIER SYSTEMS.CHEMICAL REVIEWS. VOL. 98. ISSUE 5. P. 2045 -2076 | 144 | 53% | 1344 |
3 | LOFTSSON, T , BREWSTER, ME , (2011) PHARMACEUTICAL APPLICATIONS OF CYCLODEXTRINS: EFFECTS ON DRUG PERMEATION THROUGH BIOLOGICAL MEMBRANES.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 63. ISSUE 9. P. 1119 -1135 | 125 | 59% | 73 |
4 | UEKAMA, K , (2012) NOVEL APPROACH OF CYCLODEXTRIN-BASED PHARMACEUTICAL FORMULATION.YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN. VOL. 132. ISSUE 1. P. 85 -105 | 120 | 70% | 7 |
5 | UEKAMA, K , (2004) PHARMACEUTICAL APPLICATION OF CYCLODEXTRINS AS MULTI-FUNCTIONAL DRUG CARRIERS.YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN. VOL. 124. ISSUE 12. P. 909 -935 | 146 | 71% | 23 |
6 | MURA, P , (2015) ANALYTICAL TECHNIQUES FOR CHARACTERIZATION OF CYCLODEXTRIN COMPLEXES IN THE SOLID STATE: A REVIEW.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 113. ISSUE . P. 226 -238 | 78 | 79% | 12 |
7 | GIORDANO, F , NOVAK, C , MOYANO, JR , (2001) THERMAL ANALYSIS OF CYCLODEXTRINS AND THEIR INCLUSION COMPOUNDS.THERMOCHIMICA ACTA. VOL. 380. ISSUE 2. P. 123 -151 | 139 | 62% | 160 |
8 | UEKAMA, K , (2004) DESIGN AND EVALUATION OF CYCLODEXTRIN-BASED DRUG FORMULATION.CHEMICAL & PHARMACEUTICAL BULLETIN. VOL. 52. ISSUE 8. P. 900 -915 | 97 | 73% | 200 |
9 | CHALLA, R , AHUJA, A , ALI, J , KHAR, RK , (2005) CYCLODEXTRINS IN DRUG DELIVERY: AN UPDATED REVIEW.AAPS PHARMSCITECH. VOL. 6. ISSUE 2. P. - | 130 | 63% | 42 |
10 | CARRIER, RL , MILLER, LA , AHMED, M , (2007) THE UTILITY OF CYCLODEXTRINS FOR ENHANCING ORAL BIOAVAILABILITY.JOURNAL OF CONTROLLED RELEASE. VOL. 123. ISSUE 2. P. 78-99 | 72 | 77% | 230 |
Classes with closest relation at Level 1 |